WhatiLearned.com - What I Learned
RUDN biochemists found out how ROS affect cisplatin resistance in ovarian cancer cells
A team of sciences from RUDN Institute of Medicine found out how reactive oxygen species affect the resistance of ovarian cancer cells to chemotherapy on the example of cisplatin — an antitumor drug used to treat this type of malignant growth. Practical application of the research results would help improve medical treatment schemes for cancer patients. The article of the scientists was published in the materials of FEBS Congress (FEBS Open Bio).